|
Lipopolysaccharide, a virulence factor produced by bacteria, is a toxin that can cause systemic inflammation via circulation. In a recently completed study, genetic markers were discovered that are associated with a heightened lipopolysaccharide level in the blood.
Microbes are part of the human body, and bacteria or their components often end up in the circulation. One such bacterial component is lipopolysaccharide (LPS), which is a toxin. High concentrations of LPS in the blood cause sepsis. Low LPS levels, known as endotoxemia, cause low-grade inflammation. In fact, endotoxemia commonly occurs in connection with, for example, obesity, predicting a heightened risk for both diabetes and cardiovascular diseases. In a study recently completed at the University of Helsinki, LPS levels were measured in the blood of more than 11,000 Finns, after which genome-wide association analyses were carried out to chart the link to the genome. Utilised in further analyses was the FinnGen cohort, which includes genome and disease data on close to 200,000 Finns. The study was carried out collaboratively by the University of Helsinki, the Folkhalsan Research Center, the Finnish Institute for Health and Welfare and the French Institute of Health and Medical Research (INSERM). "As an entirely new find, we identified an apparent link between the human genome and the amount of bacterial toxins in the blood," says researcher Jaakko Leskela. Low-grade inflammation linked to thrombosis Blood coagulation and defence against infections are interlinked traits, which is in fact beneficial for, for example, the healing of wounds: bleeding must be arrested, while the wound must be protected against infection. In the recently published study, a link between endotoxemia and certain genes associated with blood coagulation was found. "Our findings connected endotoxemia particularly with blood clots, strokes and other diseases related to blood coagulation," Leskela says. Consequently, the genes which have such a favourable effect on wound healing also have an unfavourable connection to low-grade inflammation in the body. "While we do not yet know how exactly these genes associated with coagulation can affect endotoxemia, demonstrating a link is a big step forward as such," Leskela notes. Further research to provide information relevant to treating low-grade inflammation The results also indicate that the quality of the human microbiome makes a difference to the risk of developing cardiovascular diseases. "We have a long road ahead of us in investigating this finding further. However, it is already clear that our results can help to discover new methods for studying and treating low-grade inflammation associated with endotoxemia," Leskela concludes. (ANI)
|
